Literature DB >> 24006637

[The analysis of status of biochemical indicators in blood serum and lacrimal fluid in patients with primary open-angle glaucoma].

Ye Yu Openkova, E N Korobeiynikova, V S Rykin, G A Vinkova.   

Abstract

The study used the sample of 94 patients with primary open-angle glaucoma. The analysis was applied to determine the level of nitric oxide metabolites in blood serum and tear, condition of end products of lipid peroxidation and activity of catalase in lacrimal fluid and also indicators of lipid metabolism in blood. The higher level of atherogenic lipids in blood was detected in the group of patients with glaucoma as compared with control group. The patients with glaucoma also characterized by increased amount of malonic dialdehyde in tear, decreasing activity of catalase and increase of concentration of nitric oxide and its metabolites in blood serum and lacrimal fluid. These occurrences testify the activation of free radical oxidation, suppression of antioxidant system of defense and presence of endothelium dysfunction under this kind of pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006637

Source DB:  PubMed          Journal:  Klin Lab Diagn        ISSN: 0869-2084


  3 in total

1.  Effects of atorvastatin on porcine aqueous humour outflow and trabecular meshwork cells.

Authors:  Lin Cong; Shuhao Fu; Jinling Zhang; Jin Zhao; Yuyan Zhang
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

2.  Native fluorescence of tear fluid as a tool for diagnostics of glaucoma.

Authors:  Kristína Krajčíková; Miriama Skirková; Monika Moravská; Anna Birková; Vladimíra Tomečková
Journal:  RSC Adv       Date:  2021-03-15       Impact factor: 3.361

Review 3.  Strategies to Reduce Oxidative Stress in Glaucoma Patients.

Authors:  Maria D Pinazo-Duran; Kian Shoaie-Nia; Vicente Zanon-Moreno; Silva M Sanz-Gonzalez; Javier Benitez Del Castillo; Jose J Garcia-Medina
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.